Deciphering the Role of the Anaphylatoxin C3a: A Key Function in Modulating the Tumor Microenvironment

被引:2
|
作者
Hanna, Jolimar [1 ,2 ]
Ah-Pine, Franck [1 ,3 ]
Boina, Chailas [1 ,2 ]
Bedoui, Yosra [1 ,3 ]
Gasque, Philippe [1 ,2 ]
Septembre-Malaterre, Axelle [1 ,2 ]
机构
[1] Univ Reunion, Unite Rech EPI Etud Pharmaco Immunol, Allee Topazes, F-97405 Saint denis, France
[2] CHU Reunion, Lab Immunol Clin & Experimentale OI LICE OI, Allee Topazes, F-97405 Saint denis, France
[3] CHU Reunion, Serv Anat & Cytol Pathol, Ave Francois Mitterrand BP450, F-97448 Saint pierre, France
关键词
tumor; anaphylatoxin C3a; complement; tumor microenvironment; COMPLEMENT ACTIVATION; SYSTEM; CANCER; IMMUNITY; RECEPTOR; REVEALS; CELLS; C5A;
D O I
10.3390/cancers15112986
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: The complement system is activated within the tumor microenvironment and its role in cancer development has raised much attention over the last decade. The aim of our study was to investigate the effects of the C3a anaphylatoxin on tumor cells (B16/F0 melanoma cell line) and two cell components of the tumor microenvironment: macrophages (Raw 264.7 Blue cell line) and mesenchymal stem cells (3T3-L1-like cell line). We showed that C3a plays a crucial role in the tumor microenvironment and may influence the tumor's fate by modulating the expression of cytokines (including IL-10, TGF beta 1), chemokines, Cox-2, and HO-1, and upregulating the oxidative stress response. We also demonstrated that C3a regulates VEGF expression, suggesting a role of the C3a/C3aR axis in angiogenesis. Our results provide novel insights into tumorigenesis and open new therapeutic avenues (C3aR antagonists) in cancer therapy. The complement system plays a crucial role in cancer development. Our study investigated the role of C3a anaphylatoxin on the tumor microenvironment. Our models consisted of mesenchymal stem cells (MSC-like, 3T3-L1), macrophages (Raw 264.7 Blue, (RB)) and tumor cells (melanoma B16/F0). Recombinant mouse (Mo) C3a (rC3a) was produced in CHO cells transfected with a Mo-IL10-signal peptide-Mo C3a plasmid construct. The effects of rC3a, IFN-gamma, TGF-beta 1, and LPS were tested on the expression of C3, C3aR, PI3K, cytokines, chemokines, transcription factors, antioxidant defense mechanisms, angiogenesis and macrophage polarization (M1/M2). 3T3-L1 expressed the highest levels of C3, while C3aR was expressed more by RB. Interestingly, expression of C3/3T3-L1 and C3aR/RB was markedly upregulated by IFN-gamma. rC3a was found to upregulate the expression of anti-inflammatory cytokines (IL-10) on 3T3-L1 and TGF-beta 1 on RB. rC3a also upregulated the expression of pro-inflammatory cytokines in RB. The expression of CCL-5 increased in 3T3-L1 in response to rC3a. On RB, rC3a did not alter M1/M2 polarization but upregulated the expression of antioxidant defense genes, HO-1, and VEGF. C3/C3a produced mainly by MSC may play a critical role in TME remodeling by stimulating both anti-inflammatory and proangiogenic activities of tumor stromal cells.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] The C3a anaphylatoxin receptor is critical in the pathophysiology of RSV infection
    Bera, Monali
    Lu, Bao
    Martin, Thomas
    Cui, Shun
    Gerard, Craig
    Gerard, Norma
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [32] The receptor for the anaphylatoxin C3a is expressed on human T lymphocytes
    Zwirner, J
    Gotze, O
    Kirchhoff, K
    Wittmann, M
    Kapp, A
    Begemann, G
    Eilers, B
    Werfel, T
    MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 308 - 308
  • [33] Candida albicans CRASP binds anaphylatoxin C3a and inhibits C3a mediated immune effector functions
    Kupka, Danny
    Luo, Shanshan
    Hippler, Uta-Christina
    Hoffmann, Ralf
    Hube, Bernhard
    Rupp, Stefan
    Zipfel, Peter F.
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2243 - 2243
  • [34] CARDIAC DYSFUNCTION CAUSED BY PURIFIED HUMAN C3A ANAPHYLATOXIN
    DELBALZO, UH
    LEVI, R
    POLLEY, MJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) : 886 - 890
  • [35] Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a/C3aR in Glioblastoma: Deciphering the Links with TGF-β and VEGF
    Ah-Pine, Franck
    Malaterre-Septembre, Axelle
    Bedoui, Yosra
    Khettab, Mohamed
    Neal, James W.
    Freppel, Sebastien
    Gasque, Philippe
    CANCERS, 2023, 15 (09)
  • [36] A RECOMBINANT HYBRID ANAPHYLATOXIN WITH DUAL C3A/C5A ACTIVITY
    BAUTSCH, W
    KRETZSCHMAR, T
    STUHMER, T
    KOLA, A
    EMDE, M
    KOHL, J
    KLOS, A
    BITTERSUERMANN, D
    BIOCHEMICAL JOURNAL, 1992, 288 : 261 - 266
  • [37] ROLE OF HISTAMINE IN THE SPASMOGENIC EFFECT OF THE COMPLEMENT PEPTIDES C3A AND C5A-DESARG (CLASSICAL ANAPHYLATOXIN)
    SORGENFREI, J
    DAMERAU, B
    VOGT, W
    AGENTS AND ACTIONS, 1982, 12 (1-2): : 118 - 121
  • [38] Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice
    Wei, Lin-Lin
    Ma, Ning
    Wu, Kun-Yi
    Wang, Jia-Xing
    Diao, Teng-Yue
    Zhao, Shu-Juan
    Bai, Liang
    Liu, Enqi
    Li, Zong-Fang
    Zhou, Wuding
    Chen, Daxin
    Li, Ke
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (09) : 2070 - 2083
  • [39] CHARACTERIZATION OF C3A ANAPHYLATOXIN RECEPTOR ON GUINEA-PIG MACROPHAGES
    MURAKAMI, Y
    IMAMICHI, T
    NAGASAWA, S
    IMMUNOLOGY, 1993, 79 (04) : 633 - 638
  • [40] A MECHANISM OF ACTION FOR ANAPHYLATOXIN C3A STIMULATION OF MAST-CELLS
    MOUSLI, M
    HUGLI, TE
    LANDRY, Y
    BRONNER, C
    JOURNAL OF IMMUNOLOGY, 1992, 148 (08): : 2456 - 2461